Distinct immune microenvironments stratify triple-negative breast cancer.

被引：0
|
作者：
Gruosso, Tina [1 ]
Kumar, Venkata Satya [2 ]
Gigoux, Mathieu [1 ]
Saleh, Sadiq [1 ]
Bertos, Nicholas [1 ]
Omeroglu, Atilla [3 ]
Zuo, Dongmei [1 ]
Meterissian, Sarkis [4 ]
Haibe-Kains, Benjamin [2 ]
Park, Morag [1 ,4 ]
机构：
[1] Goodman Canc Res Ctr, Montreal, PQ, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] McGill Univ, Dept Pathol, Montreal, PQ, Canada
[4] McGill Univ, Dept Surg, Montreal, PQ, Canada
来源：
MOLECULAR CANCER RESEARCH | 2018年 / 16卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA11
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [41] Comparison of tumor immune microenvironments (TIMEs) between primary and metastatic sites (Mets) in triple-negative breast cancer (TNBC)
    Yuan, Yuan
    Kang, Irene
    Bitar, Jin Sun
    Davis, Andrew A.
    Hilton, Christie
    Huang, Minxuan
    Thompson, Michael A.
    Mercer, Jacob
    Shiao, Stephen Lawrence
    Vail, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [42] Cancer-testis antigens in triple-negative and locally advanced breast cancer.
    Harris, Samuel John
    Turner, Natalie Heather
    Chionh, Fiona J. M.
    Walkiewicz, Marzena
    Chakrabarti, Anannya
    Deb, Siddhartha
    Cebon, Jonathan S.
    White, Shane
    John, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Ganoderma lucidum derivative fraction effects in triple-negative breast cancer.
    Ortiz-Soto, G.
    Santiago Negron, C. L.
    Suarrez Arroyo, I.
    Ling, T.
    Rivas, F.
    Martinez-Montemayor, M. M.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [44] Association between genetic susceptibility and mortality in triple-negative breast cancer.
    Akpoviroro, Ogheneyoma
    Sauers, Nathan Kyle
    Uwandu, Queeneth
    Ekechukwu, Ifunanya
    Manyele, Victoria
    Castagne, Myriam
    Srinivasa, Hema Malini
    Sharma, Namita
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Molecular classification with NanoString nCounter system in triple-negative breast cancer.
    Ahn, Sung Gwe
    Kim, Seung Joon
    Lee, Hak Woo
    Yoon, Hyo Jeong
    Kim, Chungyeul
    Jeong, Joon
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Recurrence and survival after pulmonary metastasis in triple-negative breast cancer.
    Gadiyaram, V. K.
    Kurian, S.
    Abraham, J.
    Ducatman, B.
    Hazard, H.
    Hobbs, G.
    Vona-Davis, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [47] The tumor microbiome of ER plus versus triple-negative breast cancer.
    Noguti, Juliana
    Chan, Alfred A.
    Navarrete, Marian
    Lee, Delphine J.
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 66 - 67
  • [48] The effects of Ganoderma lucidum extract fractions in Triple-Negative Breast Cancer.
    Feliciano-Ildefonso, J. J.
    Lamela, G.
    Suarez-Arroyo, I. J.
    Ling, T.
    Rivas, F.
    Cubano, L. A.
    Martinez-Montemayor, M. M.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [49] Prognostic role of androgen receptor expression in triple-negative breast cancer.
    Wang, Yanru
    Yang, Fang
    Wang, Yucai
    Zhong, Fengming
    Guan, Xiaoxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] The effects of SAHA and EGCG on metastatic potential in triple-negative breast cancer.
    Lewis, Kayla Ashlyn
    Tollefsbol, Trygve O.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 91 - 91
12345